B LYMPHOBLASTIC LYMPHOMA
Clinical trials for B LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for B LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo therapy aims to beat back childhood blood cancers
Disease control OngoingThis large phase 3 study tests whether adding the drug blinatumomab to standard chemotherapy can improve outcomes for children and young adults with newly diagnosed B-cell acute lymphoblastic leukemia or lymphoma, including those with Down syndrome. The trial enrolls over 6,700 p…
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy aims to outsmart leukemia in older patients
Disease control OngoingThis phase II trial is testing whether adding a targeted drug called inotuzumab ozogamicin to standard chemotherapy can help older adults with B-cell acute lymphoblastic leukemia or lymphoma. The study compares the combination to standard chemo alone in 68 participants. The goal …
Matched conditions: B LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC